Current Oncology

Established in 1994, Current Oncology is a peer-reviewed, Canadian based and Internationally distributed journal. Published bi-monthly plus special supplemental issues, Current Oncology represents a multidisciplinary medium encompassing health care workers in the field of cancer therapy to report upon and to review progress in the management of this disease. Current Oncology is published by Multimed Inc.

Current Oncology is indexed/covered in PubMed, EMBASE (Excerpta Medica Database), Scopus, Journal Selector, Crossref, Index Copernicus, DOAJ (Directory of Open Access Journals), Google Scholar, EMCare, Research Databases, Science Citation Index Expanded (SciSearch), and Journal Citation Reports/Science Edition. Following publication in Current Oncology, the full text of each article is available immediately and archived in PubMed Central (PMC), the U.S. National Library of Medicine's digital archive of biomedical and life sciences journal literature. It is also available in the databases of 100 libraries worldwide, and is a participant of the HINARI program.

The information provided on the Current Oncology website is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.



Job Posting: McGill University Job Opportunity > Faculty of Medicine Dept. of Oncology


Assistant Professor (Research) – Molecular genetics

Faculty of Medicine – Gerald Bronfman Department of Oncology

The Gerald Bronfman Department of Oncology wishes to attract excellent, early-career candidates to be considered for an Assistant Professor position. This faculty appointment will be part of the Contract Academic Staff.

Although our goal is to attract the best possible candidate overall, we are primarily looking for a molecular geneticist to develop a vibrant research program in the field of genetics determinants involved in pediatric low grade brain cancers.

The ideal candidate will already have secured external funding for their research program, will be required to actively seek and attract external funding from federal, provincial and private funding agencies in support of their research, and will also be expected to apply for salary support, wherever and whenever possible.

Qualifications and Education requirements
• PhD in Molecular Genetics, or related field
• At least 4 years post-doctoral research in pediatric low grade brain cancers
• Familiar with notions of neurology and/or neurophysiology
• Extensive technical experience including, but not limited to, molecular biology, genomics, cell biology, cell culture, cell-based assays, proteomic, and bioinformatics
• Strong communication and writing skills, excellent leadership skills, and a good track record of publications in peer-reviewed journals
• Clinical training will be considered an asset
• French language skills, though not essential, will be considered an asset.

To view the full job posting, please visit:

Posted: 2017-10-17

Job Posting: Career Opportunity in Palliative Medicine


William Osler Health System (Osler) is one of Ontario’s largest community hospital organizations, delivering innovative health care with compassion through more than 650,000 patient interactions every year. With three hospital sites: Brampton Civic Hospital, Etobicoke General Hospital and the new Peel Memorial Centre for Integrated Health and Wellness. We offer a wide range of health services, with care provided by skilled health professionals working in multidisciplinary teams.

We are recruiting physicians with a passion for palliative care to join our dedicated and growing Palliative Care Program at William Osler Health System. Interested candidates would be part of the interdisciplinary team working with both hospital and community providers.  Osler is a distributive campus for the McMaster Family Medicine Training program with 20 residents on site and active opportunities to teach undergraduate and postgraduate learners in Palliative Care as part of a collaborative faculty. It’s an officially designated site for the training of the Royal College sub-speciality in Palliative Medicine

The successful applicants must be licensed to practice in Ontario and hold a Fellowship from the Royal College of Physicians and Surgeons of Canada or a Certification in Family Medicine from the College of Family Physicians of Canada.  A certificate of added competency training and experience in Palliative Medicine is a requirement. 

Expressions of interest should be forwarded along with your curriculum vitae to:

Medical Staff Office

Attention: Dr. Martin Chasen, Medical Director of Palliative Care

William Osler Health System

2100 Bovaird Drive East, Brampton, ON   L6R 3J7

Tel: (905) 494-2120    Fax: (905) 494-6206  


Posted: 2017-08-02 More...

Journal Announcement: New Impact Factor of 2.048 for Current Oncology!


We are pleased to announce to our readers that Current Oncology’s 2016 Impact Factor has increased to 2.048! This is an increase from our 2015 stats, where we received an impact factor of 1.829.

The journal impact factor is a measure of citation frequency that reflects the average number of citations to articles published in science and social science journals. Impact factors are calculated annually for those journals that are indexed in Thomson Reuters Journal Citation Reports. The impact factor of a journal in a given year is the average number of citations a paper published in that journal received during the two previous years. The impact factor is often used to rank the relative importance and scientific caliber of a journal within its field.

Our 2016 Impact Factor is a significant achievement for the journal, and demonstrates the increased recognition of Current Oncology in the field, and the improved relevance and quality of our articles. Thank you to our team of Editors and Section Editors, Reviewers and Authors for their valuable contribution to the journal. We look forward to continued success in 2017 as the journal continues to strengthen and grow!

Multimed Inc.
Publisher of Current Oncology

Posted: 2017-06-29 More...
More Announcements...

Vol 24, No 4 (2017)

Table of Contents



Original Article(s)

Clinical Trials

M.D. Vincent, D. Breader, M.C. Cripps, D.J. Jonker, P. Klimo, J.J. Biagi, W. Lam, A. O'Connell, F. Whiston, L. Stitt, S.A. Welch

Integrative Oncology

L. Cohen, N. Schwartz, A. Guth, A. Kiss, E. Warner
Q. Wang, Q. Wang, S.F. Wang, L.J. Jiao, R.X. Zhang, Y. Zhong, J. Zhang, L. Xu

Medical Oncology

F. Hsu, A. De Caluwe, D. Anderson, A. Nichol, T. Toriumi, C. Ho
J. Gotfrit, M. Vickers, S. Sud, T. Asmis, C. Cripps, R. Goel, T. Hsu, D. Jonker, R. Goodwin

Psychosocial Oncology

L. Granek, L. Barbera, O. Nakash, M. Cohen, M.K. Krzyzanowska

Radiation Oncology

Y. Hatayama, M. Aoki, H. Kawaguchi, K. Hirose, M. Sato, H. Akimoto, M. Tanaka, I. Fujioka, K. Ichise, S. Ono, Y. Takai

Urologic Oncology

A. Dragomir, J. Rocha, M. Vanhuyse, F.L. Cury, W. Kassouf, J. Hu, A.G. Aprikian

Review Article(s)

R. Segal, C. Zwaal, E. Green, J. Tomasone, A. Loblaw, T. Petrella, the Exercise for People with Cancer Guideline Development Group
S. Atallah, H. Al-Assaf, Y. Xu, S. El-Sayed

Practice Guideline(s)

S. Singh, D. Sivajohanathan, T. Asmis, C. Cho, N. Hammad, C. Law, R. Wong, K. Zbuk

Short Communication(s)

K. DeCaria, D. Dudgeon, E. Green, R. Shaw Moxam, R. Rahal, J. Niu, H. Bryant
D. Berger-Richardson, E. Cordeiro, M. Ernjakovic, A.M. Easson

Case Report(s)

J.T Seki, N. Sakurai, W. Lam, D.E. Reece
N. Poddar, R. Ramlal, S. Ravulapati, S.M. Devlin, S. Gadani, C.I. Vidal, D. Cao, A.S. Befeler, J. Lai

Meeting Report(s)

P. Laneuville, J.F. Larouche, A. Tosikyan, A. Christofides
N. Chooback, B. Melosky, C. Ho

Cancer Narratives: Words Beyond Disease